Algert Global LLC Purchases New Position in Definitive Healthcare Corp. (NASDAQ:DH)

Algert Global LLC purchased a new stake in Definitive Healthcare Corp. (NASDAQ:DH) in the 2nd quarter, according to the company in its most recent Form 13F filing with the SEC. The fund purchased 231,644 shares of the company’s stock, valued at approximately $1,265,000. Algert Global LLC owned approximately 0.20% of Definitive Healthcare as of its most recent filing with the SEC.

Other large investors have also made changes to their positions in the company. Norden Group LLC acquired a new stake in Definitive Healthcare in the 1st quarter worth approximately $83,000. Susquehanna Fundamental Investments LLC acquired a new stake in Definitive Healthcare in the 1st quarter worth approximately $120,000. Canada Pension Plan Investment Board acquired a new stake in Definitive Healthcare in the 2nd quarter worth approximately $109,000. Zurcher Kantonalbank Zurich Cantonalbank lifted its holdings in Definitive Healthcare by 31.4% in the 2nd quarter. Zurcher Kantonalbank Zurich Cantonalbank now owns 21,292 shares of the company’s stock worth $116,000 after purchasing an additional 5,083 shares during the last quarter. Finally, The Manufacturers Life Insurance Company lifted its holdings in Definitive Healthcare by 17.0% in the 2nd quarter. The Manufacturers Life Insurance Company now owns 22,896 shares of the company’s stock worth $125,000 after purchasing an additional 3,332 shares during the last quarter. Institutional investors own 98.67% of the company’s stock.

Definitive Healthcare Stock Performance

Shares of NASDAQ DH opened at $4.34 on Friday. The business has a fifty day simple moving average of $4.32 and a 200 day simple moving average of $5.60. Definitive Healthcare Corp. has a one year low of $3.19 and a one year high of $10.62. The firm has a market capitalization of $511.84 million, a price-to-earnings ratio of -2.48, a PEG ratio of 6.49 and a beta of 1.33. The company has a current ratio of 2.40, a quick ratio of 2.40 and a debt-to-equity ratio of 0.27.

Definitive Healthcare (NASDAQ:DH) last announced its quarterly earnings results on Monday, August 5th. The company reported $0.09 earnings per share for the quarter, meeting analysts’ consensus estimates of $0.09. Definitive Healthcare had a positive return on equity of 0.98% and a negative net margin of 156.65%. The firm had revenue of $63.70 million for the quarter, compared to analysts’ expectations of $63.19 million. During the same period in the prior year, the business posted $0.08 earnings per share. The business’s revenue was up 4.4% compared to the same quarter last year. Sell-side analysts expect that Definitive Healthcare Corp. will post 0.07 EPS for the current year.

Analyst Ratings Changes

A number of research analysts have recently commented on the company. Robert W. Baird cut their price target on Definitive Healthcare from $6.00 to $5.00 and set a “neutral” rating for the company in a report on Wednesday, August 7th. JPMorgan Chase & Co. lowered Definitive Healthcare from a “neutral” rating to an “underweight” rating and cut their price target for the stock from $7.00 to $5.00 in a report on Wednesday, July 31st. Stifel Nicolaus cut their price target on Definitive Healthcare from $9.50 to $7.50 and set a “buy” rating for the company in a report on Wednesday, July 31st. Needham & Company LLC reiterated a “hold” rating on shares of Definitive Healthcare in a report on Tuesday, August 6th. Finally, Morgan Stanley cut their price target on Definitive Healthcare from $9.00 to $5.00 and set an “equal weight” rating for the company in a report on Tuesday, August 6th. One research analyst has rated the stock with a sell rating, seven have assigned a hold rating and three have assigned a buy rating to the company. According to MarketBeat.com, the stock presently has a consensus rating of “Hold” and a consensus price target of $5.81.

Definitive Healthcare Profile

Definitive Healthcare Corp., together with its subsidiaries, provides software as a service (SaaS) healthcare commercial intelligence platform in the United States and internationally. Its SaaS platform provides information on healthcare providers and their activities to help its customers from product development to go-to-market planning, and sales and marketing execution.